Literature DB >> 2345308

Intracellular vacuolization caused by the urease of Helicobacter pylori.

J K Xu1, C S Goodwin, M Cooper, J Robinson.   

Abstract

Tissue culture cells were exposed to supernatants of Helicobacter pylori for 24 h at 37 degrees C in the presence of various quantities of urea. In the normal human stomach the concentration of urea is less than or equal to 4 mmol/l, and in the presence of this low concentration up to 10% of Vero cells showed intracellular vacuolization. In the presence of 7.5 mmol/l urea, 25% of the cells showed vacuolization. With 30 mmol/l urea, the final pH was 7.6, indicating that vacuolization was not due to change of pH. The first report of vacuolization of tissue culture cells by H. pylori was in a system without added urea but with concentrated bacterial supernatant; 30% of H. pylori strains demonstrated a cytotoxic effect. In those experiments fetal calf serum was used; it contains 6 mmol/l urea but was used at a concentration of 10%. A urease inhibitor, acetohydroxamic acid, caused a 75% drop in the number of cells showing vacuolization, and ammonia caused vacuolization. Thus the urea of H. pylori probably causes this vacuolization.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2345308     DOI: 10.1093/infdis/161.6.1302

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Helicobacter pylori survival in gastric mucosa by generation of a pH gradient.

Authors:  G Chen; R L Fournier; S Varanasi; P A Mahama-Relue
Journal:  Biophys J       Date:  1997-08       Impact factor: 4.033

Review 2.  Helicobacter pylori and duodenal ulcer. Evidence suggesting causation.

Authors:  F Mégraud; H Lamouliatte
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

Review 3.  Helicobacter pylori and peptic ulcers: the present position.

Authors:  S Moss; J Calam
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

4.  Management of acute diarrhoea with low osmolarity oral rehydration solutions and Lactobacillus strain GG.

Authors:  T Rautanen; E Isolauri; E Salo; T Vesikari
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

5.  Urease from a potentially pathogenic coccoid isolate: purification, characterization, and comparison to other microbial ureases.

Authors:  S G Lee; D H Calhoun
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 6.  Immunopathology of Helicobacter pylori infection and disease.

Authors:  S J Czinn; J G Nedrud
Journal:  Springer Semin Immunopathol       Date:  1997

7.  Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects.

Authors:  S Khulusi; M A Mendall; P Patel; J Levy; S Badve; T C Northfield
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

8.  Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.

Authors:  K Nagata; H Satoh; T Iwahi; T Shimoyama; T Tamura
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

9.  Monoclonal antibodies against the native urease of Helicobacter pylori: synergistic inhibition of urease activity by monoclonal antibody combinations.

Authors:  K Nagata; T Mizuta; Y Tonokatu; Y Fukuda; H Okamura; T Hayashi; T Shimoyama; T Tamura
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

10.  Oral bacteriotherapy for viral gastroenteritis.

Authors:  E Isolauri; M Kaila; H Mykkänen; W H Ling; S Salminen
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.